| Primary |
| Asthma |
47.0% |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
12.7% |
| Chronic Obstructive Pulmonary Disease |
7.7% |
| Dyspnoea |
1.6% |
| Bronchitis |
1.2% |
| Cough |
1.2% |
| Cardiac Failure |
1.1% |
| Hepatitis C |
1.0% |
| Atrial Fibrillation |
0.9% |
| Prophylaxis |
0.9% |
| Hypertension |
0.8% |
| Emphysema |
0.7% |
| Pneumonia |
0.7% |
| Multiple Allergies |
0.6% |
| Polycystic Ovaries |
0.6% |
| Renal Osteodystrophy |
0.6% |
| Schizophrenia |
0.6% |
| Aspergillosis |
0.5% |
| Breast Cancer |
0.5% |
|
| Drug Ineffective |
21.8% |
| Pharmaceutical Product Complaint |
18.3% |
| Asthma |
6.2% |
| Product Quality Issue |
5.9% |
| Tachycardia |
5.4% |
| Dyspnoea |
5.2% |
| Wheezing |
5.0% |
| Tremor |
4.5% |
| Pneumonia |
4.0% |
| Metabolic Acidosis |
3.2% |
| Lactic Acidosis |
3.0% |
| Therapeutic Response Unexpected With Drug Substitution |
2.7% |
| Medication Error |
2.5% |
| Hallucination |
2.2% |
| Overdose |
2.0% |
| Vomiting |
2.0% |
| Product Substitution Issue |
1.7% |
| Convulsion |
1.5% |
| Palpitations |
1.5% |
| Unevaluable Event |
1.5% |
|
| Secondary |
| Asthma |
24.4% |
| Product Used For Unknown Indication |
21.7% |
| Chronic Obstructive Pulmonary Disease |
14.5% |
| Drug Use For Unknown Indication |
13.5% |
| Foetal Exposure During Pregnancy |
5.4% |
| Status Asthmaticus |
2.6% |
| Dyspnoea |
2.4% |
| Hypertension |
2.3% |
| Emphysema |
1.9% |
| Atrial Fibrillation |
1.5% |
| Cough |
1.5% |
| Prophylaxis |
1.4% |
| Pain |
1.2% |
| Depression |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Bipolar Disorder |
0.8% |
| Diabetes Mellitus |
0.8% |
| Smoking Cessation Therapy |
0.8% |
| Anxiety |
0.7% |
| Headache |
0.7% |
|
| Drug Ineffective |
13.3% |
| Hallucination |
11.6% |
| Tremor |
10.4% |
| Dyspnoea |
7.3% |
| Stress |
5.6% |
| Wheezing |
4.8% |
| Pulmonary Embolism |
4.4% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Death |
4.1% |
| Drug Hypersensitivity |
3.9% |
| Pharmaceutical Product Complaint |
3.6% |
| Vomiting |
3.6% |
| Lactic Acidosis |
3.4% |
| Asthma |
3.1% |
| Pneumonia |
3.1% |
| Heart Rate Increased |
2.9% |
| Wrong Technique In Drug Usage Process |
2.9% |
| Foetal Exposure During Pregnancy |
2.7% |
| Poisoning |
2.7% |
| Completed Suicide |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.8% |
| Drug Use For Unknown Indication |
18.8% |
| Asthma |
16.3% |
| Chronic Obstructive Pulmonary Disease |
10.1% |
| Pain |
4.3% |
| Hypertension |
4.2% |
| Depression |
3.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
1.9% |
| Hypersensitivity |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Osteoporosis |
1.7% |
| Smoking Cessation Therapy |
1.6% |
| Emphysema |
1.5% |
| Contraception |
1.5% |
| Dyspnoea |
1.4% |
| Prophylaxis |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Nausea |
1.0% |
|
| Vomiting |
11.4% |
| Dyspnoea |
10.0% |
| Weight Decreased |
7.2% |
| Wheezing |
6.8% |
| Pneumonia |
6.3% |
| Weight Increased |
5.9% |
| Pulmonary Embolism |
5.9% |
| Drug Ineffective |
5.5% |
| Death |
4.3% |
| Nausea |
4.3% |
| Pain |
4.1% |
| Pharmaceutical Product Complaint |
4.1% |
| Product Quality Issue |
3.6% |
| Tremor |
3.4% |
| Urticaria |
3.1% |
| Vision Blurred |
3.1% |
| Urinary Tract Infection |
2.9% |
| Asthma |
2.8% |
| Myocardial Infarction |
2.6% |
| Rash |
2.6% |
|
| Interacting |
| Asthma |
18.8% |
| Emphysema |
13.9% |
| Chronic Obstructive Pulmonary Disease |
10.9% |
| Product Used For Unknown Indication |
7.9% |
| Smoking Cessation Therapy |
7.9% |
| Osteoporosis |
5.4% |
| Bone Pain |
4.5% |
| Anxiety |
4.0% |
| Musculoskeletal Chest Pain |
4.0% |
| Intervertebral Disc Degeneration |
2.5% |
| Spinal Column Stenosis |
2.5% |
| Abdominal Discomfort |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Bursitis |
2.0% |
| Constipation |
2.0% |
| Cough |
2.0% |
| Dyspepsia |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hiv Infection |
2.0% |
| Wheezing |
2.0% |
|
| Drug Interaction |
8.6% |
| Dyspnoea |
8.6% |
| Respiratory Tract Congestion |
8.6% |
| Tachycardia |
8.6% |
| Drug Ineffective |
5.7% |
| Increased Tendency To Bruise |
5.7% |
| Musculoskeletal Chest Pain |
5.7% |
| Pain |
5.7% |
| Tremor |
5.7% |
| Weight Increased |
5.7% |
| Wheezing |
5.7% |
| Electrocardiogram Qt Prolonged |
2.9% |
| Feeling Abnormal |
2.9% |
| Neurotoxicity |
2.9% |
| Off Label Use |
2.9% |
| Pneumonia |
2.9% |
| Psychomotor Hyperactivity |
2.9% |
| Retching |
2.9% |
| Secondary Adrenocortical Insufficiency |
2.9% |
| Somnolence |
2.9% |
|
